Home
Live Updates
Taysha Gene Therapies Inc (TSHA) Reports Q3 2023 Financial Results and Clinical Progress : comparemela.com
Taysha Gene Therapies Inc (TSHA) Reports Q3 2023 Financial Results and Clinical Progress
Key Clinical Advances and Financial Position Strengthened; Cash Runway Extended into 2026
Related Keywords
Elsa Rossignol ,
Seanp Nolan ,
Data Monitoring Committee ,
Taysha Gene Therapies Inc ,
Trinity Capital ,
Gene Therapies Inc ,
Independent Data Monitoring Committee ,
Chief Executive Officer ,
Principal Investigator ,
Financial Covenants ,
Financial Position ,
Gene Therapies ,
Solid Financial Position ,
On Cash Expense ,
Adult Patient ,
Clinical Trial ,
comparemela.com © 2020. All Rights Reserved.